Works by Widström, Charles

Results: 12

Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing 177Lu-DOTA-Octreotate Treatment.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 1, p. 33, doi. 10.2967/jnumed.112.107524

By:

Sandström, Mattias;
Garske-Román, Ulrike;
Granberg, Dan;
Johansson, Silvia;
Widström, Charles;
Eriksson, Barbro;
Sundin, Anders;
Lundqvist, Hans;
Lubberink, Mark

Publication type:

Article

Ventilation Distribution Studies Comparing Technegas and "Gallgas" Using 68GaCl3 as the Label.

Published in:

Journal of Nuclear Medicine, 2011, v. 52, n. 2, p. 206, doi. 10.2967/jnumed.110.083881

By:

Borges, Joaã Batista;
Velikyan, Irina;
La°ngström, Bengt;
Sörensen, Jens;
Ulin, Johan;
Maripuu, Enn;
Sandström, Mattias;
Widström, Charles;
Hedenstierna, Göran

Publication type:

Article

Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine.

Published in:

Journal of Nuclear Medicine, 2009, v. 50, n. 5, p. 781, doi. 10.2967/jnumed.108.056929

By:

Ahlgren, Sara;
Wållberg, Helena;
Tran, Thuy A.;
Widström, Charles;
Hjertman, Magnus;
Abrahmsén, Lars;
Berndorff, Dietmar;
Dinkelborg, Ludger M.;
Cyr, John E.;
Feldwisch, Joachim;
Orlova, Anna;
Tolmachev, Vladimir

Publication type:

Article

111In-Benzyl-DTPA--ZHER2:342, an Affibody-Based Conjugate for In Vivo Imaging of HER2 Expression in Malignant Tumors.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 5, p. 846

By:

Tolmachev, Vladimir;
Nilsson, Fredrik Y.;
Widström, Charles;
Andersson, Karl;
Rosik, Daniel;
Gedda, Lars;
Wennborg, Anders;
Orlova, Anna

Publication type:

Article

Comparative In Vivo Evaluation of Technetium and Iodine Labels on an Anti-HER2 Affibody for Single-Photon Imaging of HER2 Expression in Tumors.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 3, p. 512

By:

Orlova, Anna;
Nilsson, Fredrik Y.;
Wikman, Maria;
Widström, Charles;
Ståhl, Stefan;
Carlsson, Jörgen;
Tolmachev, Vladimir

Publication type:

Article

110mIn-DTPA-D-Phe¹-Octreotide for Imaging of Neuroendocrine Tumors with PET.

Published in:

Journal of Nuclear Medicine, 2002, v. 43, n. 10, p. 1391

By:

Lubberink, Mark;
Tolmachev, Vladimir;
Widström, Charles;
Bruskin, Alexander;
Lundqvist, Hans;
Westlin, Jan-Erik

Publication type:

Article

Calculation of left ventricular volumes and ejection fraction from dynamic cardiac-gated O-water PET/CT: 5D-PET.

Published in:

EJNMMI Physics, 2017, v. 4, n. 1, p. 1, doi. 10.1186/s40658-017-0195-2

By:

Nordström, Jonny;
Kero, Tanja;
Harms, Hendrik;
Widström, Charles;
Flachskampf, Frank;
Sörensen, Jens;
Lubberink, Mark

Publication type:

Article

Irradiation-Induced Expression of Hyaluronan (HA) Synthase 2 and Hyaluronidase 2 Genes in Rat Lung Tissue Accompanies Active Turnover of HA and Induction of Types I and III Collagen Gene Expression.

Published in:

American Journal of Respiratory Cell & Molecular Biology, 2000, v. 23, n. 3, p. 411, doi. 10.1165/ajrcmb.23.3.4102

By:

Yuejuan Li;
Rahmanian, Mehdi;
Widström, Charles;
Lepperdinger, Gunter;
Frost, Gregory I.;
Heldin, Paraskevi

Publication type:

Article

Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX:1 Affibody molecule.

Published in:

International Journal of Oncology, 2015, v. 46, n. 2, p. 513, doi. 10.3892/ijo.2014.2782

By:

HONARVAR, HADIS;
GAROUSI, JAVAD;
GUNNERIUSSON, ELIN;
HÖIDÉN-GUTHENBERG, INGMARIE;
ALTAI, MOHAMED;
WIDSTRÖM, CHARLES;
VLADIMIR TOLMACHEV, VLADIMIR;
FREJD, FREDRIK Y.

Publication type:

Article

Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 12, p. 2245, doi. 10.1007/s00259-008-0845-7

By:

Ekblad, Torun;
Tran, Thuy;
Orlova, Anna;
Widström, Charles;
Feldwisch, Joachim;
Abrahmsén, Lars;
Wennborg, Anders;
Karlström, Amelie Ericksson;
Tolmachev, Vladimir

Publication type:

Article

99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2007, v. 34, n. 11, p. 1843, doi. 10.1007/s00259-007-0474-6

By:

Engfeldt, Torun;
Tran, Thuy;
Orlova, Anna;
Widström, Charles;
Feldwisch, Joachim;
Abrahmsen, Lars;
Wennborg, Anders;
Karlström, Amelie;
Tolmachev, Vladimir

Publication type:

Article

Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2007, v. 34, n. 5, p. 722, doi. 10.1007/s00259-006-0266-4

By:

Engfeldt, Torun;
Orlova, Anna;
Tran, Thuy;
Bruskin, Alexander;
Widström, Charles;
Karlström, Amelie;
Tolmachev, Vladimir

Publication type:

Article

Works by Widström, Charles

Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing <sup>177</sup>Lu-DOTA-Octreotate Treatment.

Ventilation Distribution Studies Comparing Technegas and "Gallgas" Using <sup>68</sup>GaCl<sub>3</sub> as the Label.

Targeting of HER2-Expressing Tumors with a Site-Specifically <sup>99m</sup>Tc-Labeled Recombinant Affibody Molecule, Z<sub>HER2:2395</sub>, with C-Terminally Engineered Cysteine.

<sup>111</sup>In-Benzyl-DTPA--Z<sub>HER2:342</sub>, an Affibody-Based Conjugate for In Vivo Imaging of HER2 Expression in Malignant Tumors.

Comparative In Vivo Evaluation of Technetium and Iodine Labels on an Anti-HER2 Affibody for Single-Photon Imaging of HER2 Expression in Tumors.

<sup>110m</sup>In-DTPA-D-Phe¹-Octreotide for Imaging of Neuroendocrine Tumors with PET.

Calculation of left ventricular volumes and ejection fraction from dynamic cardiac-gated O-water PET/CT: 5D-PET.

Irradiation-Induced Expression of Hyaluronan (HA) Synthase 2 and Hyaluronidase 2 Genes in Rat Lung Tissue Accompanies Active Turnover of HA and Induction of Types I and III Collagen Gene Expression.

Imaging of CAIX-expressing xenografts in vivo using <sup>99m</sup>Tc-HEHEHE-ZCAIX:1 Affibody molecule.

Development and preclinical characterisation of <sup>99m</sup>Tc-labelled Affibody molecules with reduced renal uptake.

<sup>99m</sup>Tc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule.

Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the <sup>99m</sup>Tc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence.